Australia markets open in 1 minute

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.2562-0.0438 (-14.60%)
At close: 04:00PM EDT
0.2535 -0.00 (-1.05%)
After hours: 07:57PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
1,946
1,618
23.02
0
0
Cost of revenue
286.127
328.118
86.712
-
-
Gross profit
1,660
1,290
-63.692
-
-
Operating expenses
Research development
354.368
590.476
6,555
3,416
4,095
Selling general and administrative
8,918
8,851
6,429
3,738
3,920
Total operating expenses
9,272
9,442
12,984
7,154
8,015
Operating income or loss
-7,612
-8,152
-13,047
-7,154
-8,015
Interest expense
499.999
500.05
112.994
-
-
Total other income/expenses net
-
105.13
-
-
433.392
Income before tax
-8,106
-8,538
-13,155
-7,126
-7,566
Income from continuing operations
-8,106
-8,538
-13,155
-7,126
-7,566
Net income
-8,106
-8,538
-13,155
-7,126
-7,566
Net income available to common shareholders
-8,106
-8,538
-13,155
-7,126
-7,566
Basic EPS
-
-
-0.52
-0.32
-0.46
Diluted EPS
-
-
-0.52
-0.32
-0.46
Basic average shares
-
-
25,492
22,296
16,602
Diluted average shares
-
-
25,492
22,296
16,602
EBITDA
-
-8,038
-13,042
-7,154
-8,015